Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors of .beta.-glucuronidase and their use in the treatment of carcinamatosis and inflammation

Inhibitors of .beta.-glucuronidase and their use in the treatment of carcinamatosis and inflammation

US Patent 5817800 · Granted Oct 6, 1998

Estimated economic value: $616,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Apramycin derivatives2022
Neomycin and paromomycin derivatives2022
Treatment of bacterial infectious diseases2016
Immunoconjugate for human CD66 for the treatment of multiple myeloma and other h2015
Screening assay for ribosomal antibiotics2014
Bifunctional glycoproteins having a modified carbohydrate complement and their u2013
Aminoglycoside antibiotics targeting bacterial 16S ribosomal RNA2013
Chimeric antibody against tumor associated antigens and its use in diagnosing tu2010
Effector conjugates, methods for their preparation and their pharmaceutical use2009
Effector conjugates, process for their production and their pharmaceutical use2008
Cytoplasmic expression of antibodies, antibody fragments and antibody fragment f2008
Fusion proteins for prodrug activation2007